Citius Pharmaceuticals

Graphic of a fork in the road with arrows pointing in either direction

Pharma

UPDATED: Citius Oncology weighs strategic options

The company had initially hoped to launch its T-cell lymphoma treatment Lymphir within five months of the August FDA nod.

Zoey Becker Jan 6, 2025 11:28am

green light go go ahead advance yes streetlight

FDA approves Citius' Lymphir for cutaneous T-cell lymphoma

Aug 8, 2024 11:21am